Home›Stock Screener›Astonea Labs

Astonea Labs Share Price Today | Stock Price & Astonea Labs Share Screener

ASTONEALAB Pharmaceuticals

Track the current Astonea Labs share price and stock price live with TickJournal's free stock screener. Check Astonea Labs yearly highs lows for the annual price range and momentum. Use the Astonea Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Astonea Labs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Astonea Labs Market Cap ₹355.30 Cr.
ASTONEALAB P/E Ratio (TTM) -
Astonea Labs P/B Ratio 6.22
EPS (TTM) ₹4.49
Dividend Yield -
Debt to Equity 1.28
ASTONEALAB 52 Week High -
Astonea Labs 52 Week Low -
Operating Margin -
Profit Margin -
ASTONEALAB Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹146.00
Total Equity ₹57.00

Astonea Labs Share Price Chart

Track the current stock price of Astonea Labs with an interactive chart. Analyse ASTONEALAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Astonea Labs stock quote in one place.

Astonea Labs Company Profile - Fundamental Screener

Screen Astonea Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTONEALAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0TG901011.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0TG901011

Astonea Labs Balance Sheet Screener

Screen ASTONEALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹146, up from ₹103 in 2025.

Latest statistics put total assets at ₹146 and shareholder funds at ₹57, with a leverage ratio of 1.28.

Item 2026 2025

Assets

Total Assets 146 103
Current Assets 98 71
Fixed Assets 31 26

Liabilities

Total Liabilities 0 0
Current Liabilities 21 20
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 57 18
Share Capital 11 8
Reserves & Surplus 47 11

Astonea Labs Income Statement Screener - Profit & Revenue Analysis

Screen Astonea Labs income statement and profit fundamentals. Analyze ASTONEALAB quarterly results. Astonea Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹148 and net profit of ₹5.

Item None-None 2026-March 2025-March

Revenue and Expenses

Revenue 0 148 98
Expenses 0 134 82

Operating Costs and Margins

EBITDA 0 14 15
Operating Profit % 0.00% 9.00% 16.00%
Depreciation 0 5 5
Interest 0 3 4

Profit and Earnings

Profit Before Tax 0 6 7
Tax 0 1 2
Net Profit 0 5 5
EPS 0.00 4.49 6.94

Astonea Labs Cash Flow Screener - Liquidity Fundamentals

Screen ASTONEALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹14.

Over the same period, investing activities used ₹20 and financing activities provided ₹34.

Item 2026-March 2025-March

Cash from Operations and Investing

Operating Activities -14 9
Investing Activities -20 -11

Financing and Net Cash

Financing Activities 34 2
Net Cash Flow 0 0

Astonea Labs Shareholding Pattern Screener

See Astonea Labs shareholding pattern with promoter, FII, and DII holdings. Check Astonea Labs promoter holding and ownership changes for ASTONEALAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.30%, foreign institutions 0.00%, domestic institutions 0.07% and the public 22.25%, spread across 376 shareholders.

The shareholder count was 376 in 2026-Mar, compared with 36 in 2025-May.

Item 2026-Mar 2025-May 2025-Jun 2025-Sept 2024-Aug

Promoter Holding

Promoter Holding 72.30% 72.30% 72.30% 72.30% 98.43%

Institutional Investors

FII Holding 0.00% 0.00% 8.01% 2.51% 0.00%
DII Holding 0.07% 0.00% 4.55% 0.35% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 22.25% 12.24% 11.51% 17.06% 0.00%
Other Holding 5.38% 15.45% 3.62% 7.77% 1.57%
Shareholder Count 376 36 1,014 437 36

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Astonea Labs. Astonea Labs dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Astonea Labs.

Astonea Labs Stock Index Membership - Nifty & Sensex

See which indices include Astonea Labs stock. Check ASTONEALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 1 indices, including BSE SME IPO.

Complete Index List

BSE SME IPO

Astonea Labs Market Events Screener - Corporate Actions

Get Astonea Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Astonea Labs stock events that may affect ASTONEALAB share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Annual General Meeting dated August 21, 2026, with a record date of August 21, 2026.

It is followed by Quarterly Result Announcement dated July 24, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-21 2026-08-21 Annual General Meeting NA 6.59%
2026-07-24 2026-07-24 Quarterly Result Announcement NA -5.85%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 1.56%
2026-03-27 2026-03-27 Extraordinary General Meeting NA 1.29%
2025-12-27 2025-12-27 Annual General Meeting NA 6.70%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 2.50%
2025-07-11 2025-07-11 Quarterly Result Announcement NA 3.94%

Astonea Labs Competitors Screener - Peer Stocks Comparison

Screen ASTONEALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 47.42
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 48.14
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 61.81
Cipla 111,426 33.44 29,045 2.24% 3,870 44.03
Laurus Labs 106,838 99.70 6,868 22.01% 890 58.00
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 69.59
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.69
Lupin 93,829 16.99 29,039 26.75% 5,356 34.02

Astonea Labs Company Announcements - News & Reports Screener

Screen ASTONEALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated September 29, 2026 and September 26, 2026.

Date Update Actions
2026-10-02 Closure of Trading Window -
2026-09-29 Resubmission Of Financial Results For The Half Year Ended 31.03.2025 In Response To BSE Communication -
2026-09-26 Resubmission Of Financial Results For The Financial Year Ended 31.03.2025 In Response To BSE Communication -
2026-09-18 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-09-17 Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulation 2015. -
2026-09-17 Disclosures Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011. -
2026-09-09 Appointment Of Internal Auditor -
2026-09-09 Board Meeting Outcome for Meeting Held On 9Th September 2026. -
2026-08-21 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2026-08-21 Re-Appointment Of Ms. Pooja Singh As Director Of The Company -
2026-08-21 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-21 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-25 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-24 Reg. 34 (1) Annual Report. -
2026-07-24 Notice Of 9Th Annual General Meeting ("AGM") Of The Company For The Financial Year 2025-26 -
2026-07-24 Revision In Re-Appointment Of Tax Auditor -
2026-07-24 Audited Consolidated Financial Results For The Half Year And Year Ended 31.03.2026 -
2026-07-24 Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 24Th July 2026 -
2026-07-18 Board Meeting Intimation for Approval Of Audited Consolidated Financial Results For The Financial Year Ended 31.03.2026 And Others. -
2026-07-17 Intimation Under Regulation 30-Execution And Registration Of Sale Deed For Sale Of Immovable Properties. -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 6.22. Market capitalisation stands at ₹355.30 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.